XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
 12 Months Ended
Jul. 02, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Plans
The following table summarizes activity of the Company’s stock option plans since June 30, 2019: 
 Options Outstanding
 Number of
Shares		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as
of 7/2/2021
Outstanding at June 30, 20194 $5.52 2.13
Granted— — 
Exercised(1)5.52 
Cancelled— — 
Outstanding at July 3, 20203 $5.52 1.12
Granted— — 
Exercised(3)5.52 
Cancelled— — 
Outstanding at July 2, 2021— $— — $— 
Vested and expected to vest at July 2, 2021— $— — $— 
Exercisable at July 2, 2021— $— — $— 
Summary of Nonvested Restricted Stock
The following table summarizes the status of the Company’s non-vested restricted stock awards since June 30, 2019:
 Non-Vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Outstanding at June 30, 20191,046 $39.62 
Granted522 80.87 
Vested(562)31.40 
Forfeited(49)54.96 
Outstanding at July 3, 2020957 $61.59 
Granted570 76.03 
Vested(436)53.08 
Forfeited(78)69.54 
Outstanding at July 2, 20211,013 $70.77 
Stock Based Compensation Expenses The following table presents share-based compensation expenses from continuing operations included in the Company’s Consolidated Statements of Operations and Comprehensive Income:
 Fiscal Years Ended
 July 2, 2021July 3, 2020June 30, 2019
Cost of revenues$2,037 $989 $820 
Selling, general and administrative21,866 21,688 16,188 
Research and development4,387 3,861 2,414 
Stock-based compensation expense before tax28,290 26,538 19,422 
Income taxes(7,355)(6,900)(5,263)
Stock-based compensation expense, net of income taxes$20,935 $19,638 $14,159